+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Infectious Disease Diagnostics Market by Product (Assays and Kits, Instruments, and Software & Services), Technology (Immunodiagnostics, NGS, PCR), Disease Type (Hepatitis, HIV, HPV, Tuberculosis), End User, and Geography - Global Forecast to 2025

  • ID: 4790449
  • Report
  • Region: Global
  • 167 Pages
  • Meticulous Market Research Pvt. Ltd.
UP TO OFF
until Dec 31st 2019
1 of 3
Infectious Disease Diagnostics Market Worth $23.4 billion by 2025

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux
  • Danaher
  • DiaSorin S.P.A.
  • F. Hoffmann-La Roche Ltd
  • Meridian Bioscience, Inc.
  • MORE

Infectious Disease Diagnostics Market by Product (Assays and Kits, Instruments, and Software & Services), Technology (Immunodiagnostics, NGS, PCR), Disease Type (Hepatitis, HIV, HPV, Tuberculosis), End User, and Geography-Global Forecast to 2025

The global infectious disease diagnostics market is expected to grow at a CAGR of 5.9%

Succeeding an extensive secondary and primary research and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and challenges. The factors such as increasing global prevalence of infectious diseases, growing awareness of early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing are driving the growth of this market. However, unfavorable and inadequate reimbursement scenarios may hamper the growth of this market to a certain extent.

On the basis of product type, the assays and kits segment dominated the global infectious disease diagnostics market in 2018, owing to the increasing prevalence of infectious diseases, rising awareness among the population to identify the diseases, and increasing use of kits and reagents to identify the organism causing various diseases in lesser time and cost.

On the basis of technology, immunodiagnostics accounted for the largest share of the global infectious disease diagnostics market. This is owing to the increasing use of immunoassays in POC infectious disease testing, the development of novel tests, the rising trend of automation, increasing awareness about health and fitness, and reduced complications associated with the instruments.

The hepatitis segment held the largest share of the infectious disease diagnostics market. This is mainly attributed to the increasing prevalence of hepatitis B & C infection, rising susceptibility of the geriatric population, growing awareness among the population, and the increasing availability of various molecular diagnostic technologies.

Based on the end user, the hospital/clinical laboratories segment held the major share in 2018. This is primarily attributed to the increasing number of outpatients for infectious diseases, increasing hospital expenditures, growing technological advancement for diagnostic platforms in hospitals, and an increasing number of skilled professionals.

An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global infectious disease diagnostics market in 2018, followed by Europe and Asia Pacific. The large share of this region is mainly attributed to the factors such as growing healthcare sector, increasing need to treat various infectious diseases, growing healthcare expenditure, increasing demand of point-of-care testing, increase in the research and development coupled with the development of novel advanced technologies for diagnosis, and a large number of patient population.

The major players operating in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience, Inc. (U.S.), Quidel Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.) among others.

Scope of the Report:

Infectious Disease Diagnostics Market, by Product

  • Assays and Kits
  • Instruments
  • Software & Services

Infectious Disease Diagnostics Market, by Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • DNA Microarray
  • Other Technologies

Infectious Disease Diagnostics Market, by Disease Type

  • Hepatitis
  • HIV
  • Hospital-Acquired Infections
  • HPV
  • Tuberculosis
  • Influenza
  • Other Infectious Diseases

Infectious Disease Diagnostics Market, by End User

  • Hospital/Clinical laboratories
  • Reference Laboratories
  • Academics/Research Institutes
  • Other End User

Infectious Disease Diagnostics Market, by Region

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • bioMérieux
  • Danaher
  • DiaSorin S.P.A.
  • F. Hoffmann-La Roche Ltd
  • Meridian Bioscience, Inc.
  • MORE

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary
3.1. Introduction
3.2. Market Dynamics
3.3. Product Segment Analysis
3.4. Technology Segment Analysis
3.5. Disease Type Segment Analysis
3.6. End User Segment Analysis
3.7. Regional Analysis
3.8. Competitive Analysis

4. Market insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Global Prevalence of Infectious Diseases
4.2.2. Growing Awareness for Early Detection Using Specific Diagnostic Tests
4.2.3. Growth in Funding for Research on Infectious Disease Diagnostics
4.2.4. Shift in Focus from Centralized Laboratories to Decentralized Point-Of-Care Testing
4.3. Restraints
4.3.1. Unfavorable and inadequate Reimbursement Scenario
4.4. Challenges
4.4.1. Lack of Awareness of Specific Symptoms and Diagnosis of Emerging Infections
4.5. Opportunities
4.5.1. Advances in Genomics and Proteomics
4.5.2. Growing Awareness about Personalized Medicines
4.5.3. Growth Opportunities in Emerging Economies

5. Global Infectious Disease Diagnostics Market, by Product and Services
5.1. Introduction
5.2. Assays and Kits
5.3. Instruments
5.4. Software and Services

6. Global Infectious Disease Diagnostics Market, by Technology
6.1. Introduction
6.2. Immunodiagnostics
6.3. Clinical Microbiology
6.4. Polymerase Chain Reaction (PCR)
6.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.6. DNA Sequencing & Next-Generation Sequencing (NGS)
6.7. DNA Microarray
6.8. Other Technologies

7. Global Infectious Disease Diagnostics Market, by Disease Type
7.1. Introduction
7.2. Hepatitis
7.3. HIV
7.4. Hospital-Acquired infections (HAIS)
7.5. Human Papillomavirus (HPV)
7.6. Tuberculosis (TB)
7.7. Influenza
7.8. Other Infectious Diseases

8. Global Infectious Disease Diagnostics Market, by End User
8.1. Introduction
8.2. Hospital/Clinical Laboratories
8.3. Reference Laboratories
8.4. Academics/Research Institutes
8.5. Other End Users

9. Infectious Disease Diagnostics Market, by Region
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Rest of Europe (RoE)
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. Rest of Asia Pacific (ROAPAC)
9.5. Latin America
9.6. Middle East and Africa

10. Competitive Landscape
10.1. Overview
10.2. Inorganic Growth Strategies
10.2.1. Agreements, Collaborations, and Partnerships
10.2.2. Acquisitions
10.3. Organic Growth Strategies
10.3.1. Product and Service Launches
10.4. Market Positioning/Ranking
10.5. Performance of the Key Players
10.5.1. F. Hoffmann-La Roche Ltd
10.5.2. Abbott Laboratories
10.5.3. Danaher Corporation
10.5.4. BD

11. Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. Abbott Laboratories
11.2. Danaher
11.3. Bio-Rad Laboratories, Inc.
11.4. bioMérieux
11.5. F. Hoffmann-La Roche Ltd
11.6. BD (Becton, Dickinson, and Company)
11.7. DiaSorin S.P.A.
11.8. Meridian Bioscience, Inc.
11.9. Quidel Corporation
11.10. Thermo Fisher Scientific Inc.

12. Appendix
12.1. Questionnaire
12.2. Available Customization

List of Tables
Table 1 Clinical Applications of Infectious Disease Genomics and Proteomics
Table 2 Assays and Kits Market Size, by Country/ Region, 2016-2025 ($Million)
Table 3 Instruments Market Size, by Country/Region, 2016-2025 ($Million)
Table 4 Software and Services Market Size, by Country/Region, 2016-2025 ($Million)
Table 5 Immunodiagnostics Market Size, by Country/Region, 2016-2025 ($Million)
Table 6 Clinical Microbiology Market Size, by Country/Region, 2016-2025 ($Million)
Table 7 Polymerase Chain Reaction (PCR) Market Size, by Country/Region, 2016-2025 ($Million)
Table 8 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size, by Country/Region, 2016-2025 ($Million)
Table 9 DNA Sequencing & Next-Generation Sequencing (NGS) Market Size, by Country/Region, 2016-2025 ($Million)
Table 10 DNA Microarray Market Size, by Country/Region, 2016-2025 ($Million) 46
Table 11 Other Technologies Market Size, by Country/Region, 2016-2025 ($Million)
Table 12 Hepatitis Disease Diagnostics Market Size, by Country/Region, 2016-2025 ($Million)
Table 13 HIV Disease Diagnostics Market Size, by Country/Region, 2016-2025 ($Million)
Table 14 Hospital-Acquired infections Disease Diagnostics Market Size, by Country/Region, 2016-2025 ($Million)
Table 15 Human Papillomavirus (HPV) Disease Diagnostics Market Size, by Country/Region, 2016-2025 ($Million)
Table 16 Tuberculosis Disease Diagnostics Market Size, by Country/Region, 2016-2025 ($Million)
Table 17 Influenza Disease Diagnostics Market Size, by Country/Region, 2016-2025 ($Million)
Table 18 Other Infectious Diseases Diagnostics Market Size, by Country/Region, 2016-2025 ($Million)
Table 19 Infectious Disease Diagnostics Market Size for Hospital/Clinical Laboratories, by Country/Region 2016-2025 ($Million)
Table 20 Infectious Disease Diagnostics Market Size for Reference Laboratories, by Country/Region, 2016-2025 ($Million)
Table 21 Infectious Disease Diagnostics Market Size for Academics/Research institutes, by Country/Region, 2016-2025 ($Million)
Table 22 Infectious Disease Diagnostics Market Size for Other End User, by Country/Region, 2016-2025, ($Million)
Table 23 North America: Infectious Disease Diagnostics Market Size, by Country, 2016-2025 ($Million)
Table 24 North America: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 25 North America: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 26 North America: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 27 North America: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 28 U.S.: Disease Rates and Number of New Cases (2015 & 2016)
Table 29 U.S.: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 30 U.S.: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 31 U.S.: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 32 U.S.: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 33 Canada: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 34 Canada: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 35 Canada: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 36 Canada: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 37 Europe: Infectious Disease Diagnostics Market Size, by Country, 2016-2025 ($Million)
Table 38 Europe: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 39 Europe: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 40 Europe: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 41 Europe: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 42 Germany: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 43 Germany: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 44 Germany: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 45 Germany: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 46 U.K. Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 47 U.K. Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 48 U.K. Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 49 U.K. Infectious Disease Diagnostics Market, by End User, 2016-2025 ($Million)
Table 50 France: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 51 France: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 52 France: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 53 France: Infectious Disease Diagnostics Market, by End User, 2016-2025 ($Million)
Table 54 Hepatitis A Cases in 2016 and 2017
Table 55 Rest of Europe (RoE): Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 56 Rest of Europe (RoE): Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 57 Rest of Europe (RoE): Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 58 Rest of Europe (RoE): Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 59 Asia Pacific: Infectious Disease Diagnostics Market Size, by Country, 2016-2025 ($Million)
Table 60 Asia Pacific: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 61 Asia Pacific: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 62 Asia Pacific: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 63 Asia Pacific: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 64 China: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 65 China: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 66 China: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 67 China: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 68 Japan: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 69 Japan: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 70 Japan: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 71 Japan: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 72 RoAPAC: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 73 RoAPAC: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 74 RoAPAC: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 75 RoAPAC: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 76 Latin America: Infectious Disease Diagnostics Market Size, by Country, 2016-2025 ($Million)
Table 77 Latin America: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 78 Latin America: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 79 Latin America: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 80 Latin America: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 81 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Country, 2016-2025 ($Million)
Table 82 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Product and Services, 2016-2025 ($Million)
Table 83 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Technology, 2016-2025 ($Million)
Table 84 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Disease Type, 2016-2025 ($Million)
Table 85 Middle East & Africa: Infectious Disease Diagnostics Market Size, by End User, 2016-2025 ($Million)
Table 86 Meridian Bioscience, Inc.: Financial Overview (2016-2018)

List of Figures
Figure 1 Key Stakeholders in the Infectious Disease Diagnostics Market
Figure 2 Key Executives interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Global Infectious Disease Diagnostics Market, 2016-2025 ($ Million)
Figure 6 Infectious Disease Diagnostics Product: Global Market Outlook, 2018 VS. 2025
Figure 7 Infectious Disease Diagnostics Technology: Global Market Outlook, 2018 VS. 2025
Figure 8 Infectious Disease Diagnostics Disease Type: Global Market Outlook, 2018 VS. 2025
Figure 9 Infectious Disease Diagnostics End User: Global Market Outlook, 2018 VS. 2025
Figure 10 Infectious Disease Diagnostics: Regional Market Outlook, 2018 VS. 2025
Figure 11 Market Dynamics
Figure 12 Infectious Disease Diagnostics Market Size, by Product and Services, 2018-2025 ($Million)
Figure 13 Global Infectious Disease Diagnostics Market Size, by Technology, 2018-2025 ($Million)
Figure 14 Global Infectious Disease Diagnostics Market Size, by Disease Type, 2018-2025 ($Million)
Figure 15 Global Infectious Disease Diagnostics Market Size, by End User, 2018-2025 ($Million)
Figure 16 North America: Infectious Disease Diagnostics Market Size, by Country, 2018-2025 ($Million)
Figure 17 Europe: Infectious Disease Diagnostics Market Size, by Country, 2018-2025 ($Million)
Figure 18 Asia Pacific: Infectious Disease Diagnostics Market Size, by Country, 2018-2025 ($Million)
Figure 19 Latin America: Infectious Disease Diagnostics Market Size, by Country, 2018-2025 ($Million)
Figure 20 Middle East & Africa: Infectious Disease Diagnostics Market Size, by Country, 2018-2025 ($Million)
Figure 21 Growth Strategies of the Prominent Players
Figure 22 Agreements, Collaborations, and Partnerships
Figure 23 Acquisitions
Figure 24 Product and Service Launches
Figure 25 Key Companies: Market Positioning/Ranking
Figure 26 Abbott Laboratories: Financial Overview (2016-2018)
Figure 27 Danaher: Financial Overview (2016-2018)
Figure 28 Bio-Rad Laboratories, Inc.: Financial Overview (2016-2018)
Figure 29 bioMérieux: Financial Overview (2016-2018)
Figure 30 F. Hoffmann-La Roche Ltd: Financial Overview (2016-2018)
Figure 31 BD (Becton, Dickinson, and Company): Financial Overview (2016-2018)
Figure 32 DiaSorin S.P.A.: Financial Overview (2016-2018)
Figure 33 Quidel Corporation: Financial Overview (2016-2018)
Figure 34 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018)

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • BD (Becton, Dickinson, and Company)
  • Bio-Rad Laboratories, Inc.
  • bioMérieux
  • Danaher
  • DiaSorin S.P.A.
  • F. Hoffmann-La Roche Ltd
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll